Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.

<h4>Background and aim</h4>Apparently healthy individuals with elevated serum alpha-fetoprotein (AFP) levels (>7 ng/mL) for unknown causes visit clinics. We investigated their clinical characteristics, outcomes, and relationship with body fat deposition and muscle mass.<h4>Metho...

Full description

Bibliographic Details
Main Authors: Sangmi Jang, Gwang Hyeon Choi, Won Chang, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0271407
_version_ 1818041240105517056
author Sangmi Jang
Gwang Hyeon Choi
Won Chang
Eun Sun Jang
Jin-Wook Kim
Sook-Hyang Jeong
author_facet Sangmi Jang
Gwang Hyeon Choi
Won Chang
Eun Sun Jang
Jin-Wook Kim
Sook-Hyang Jeong
author_sort Sangmi Jang
collection DOAJ
description <h4>Background and aim</h4>Apparently healthy individuals with elevated serum alpha-fetoprotein (AFP) levels (>7 ng/mL) for unknown causes visit clinics. We investigated their clinical characteristics, outcomes, and relationship with body fat deposition and muscle mass.<h4>Methods</h4>The case group included asymptomatic 137 individuals with "elevated AFP level" (R772) diagnostic code from 2009 to 2018 in a tertiary hospital. The control group enrolled 274 age- and sex-matched patients with <5 cm hepatic hemangiomas. Hepatic, visceral, and psoas muscle adiposity and psoas muscle index (PMI) were measured in the subgroups of 45 cases and 90 controls with pre-contrast computed tomography (CT) images.<h4>Results</h4>The case group (mean age 47.5 years, male 35.8%) showed higher AFP levels (10.3 vs 2.5 ng/mL, p<0.001) and total bilirubin (0.8 vs 0.7 mg/dL, p<0.001), but a lower body mass index (22.2 vs 23.3 kg/m2, p = 0.011) and alanine aminotransferase levels (17.0 vs 19.0 IU/L, p = 0.047) than the controls. During 13 months of median follow-up, there was no cancer or liver disease development. The AFP levels were stable. In the subgroups with CT images, cases showed a lower proportion of hepatic steatosis (4.4% vs 18.9%, p = 0.023), higher psoas muscle attenuation (48.2 vs 43.8 Hounsfield units, p<0.001) and higher PMI (5.7 vs 4.2 cm2/m2, p<0.001) than the controls.<h4>Conclusion</h4>Elevated AFP levels in asymptomatic individuals may play a role in expressing a protective phenotype against hepatic steatosis, myosteatosis, and sarcopenia. AFP levels in patients with elevated AFP were stable during follow-up without liver injury or cancer development. Interaction between AFP expression and steatosis warrants further study.
first_indexed 2024-12-10T08:27:16Z
format Article
id doaj.art-88c29424314c4669888d16d9f64bc25f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T08:27:16Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-88c29424314c4669888d16d9f64bc25f2022-12-22T01:56:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01177e027140710.1371/journal.pone.0271407Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.Sangmi JangGwang Hyeon ChoiWon ChangEun Sun JangJin-Wook KimSook-Hyang Jeong<h4>Background and aim</h4>Apparently healthy individuals with elevated serum alpha-fetoprotein (AFP) levels (>7 ng/mL) for unknown causes visit clinics. We investigated their clinical characteristics, outcomes, and relationship with body fat deposition and muscle mass.<h4>Methods</h4>The case group included asymptomatic 137 individuals with "elevated AFP level" (R772) diagnostic code from 2009 to 2018 in a tertiary hospital. The control group enrolled 274 age- and sex-matched patients with <5 cm hepatic hemangiomas. Hepatic, visceral, and psoas muscle adiposity and psoas muscle index (PMI) were measured in the subgroups of 45 cases and 90 controls with pre-contrast computed tomography (CT) images.<h4>Results</h4>The case group (mean age 47.5 years, male 35.8%) showed higher AFP levels (10.3 vs 2.5 ng/mL, p<0.001) and total bilirubin (0.8 vs 0.7 mg/dL, p<0.001), but a lower body mass index (22.2 vs 23.3 kg/m2, p = 0.011) and alanine aminotransferase levels (17.0 vs 19.0 IU/L, p = 0.047) than the controls. During 13 months of median follow-up, there was no cancer or liver disease development. The AFP levels were stable. In the subgroups with CT images, cases showed a lower proportion of hepatic steatosis (4.4% vs 18.9%, p = 0.023), higher psoas muscle attenuation (48.2 vs 43.8 Hounsfield units, p<0.001) and higher PMI (5.7 vs 4.2 cm2/m2, p<0.001) than the controls.<h4>Conclusion</h4>Elevated AFP levels in asymptomatic individuals may play a role in expressing a protective phenotype against hepatic steatosis, myosteatosis, and sarcopenia. AFP levels in patients with elevated AFP were stable during follow-up without liver injury or cancer development. Interaction between AFP expression and steatosis warrants further study.https://doi.org/10.1371/journal.pone.0271407
spellingShingle Sangmi Jang
Gwang Hyeon Choi
Won Chang
Eun Sun Jang
Jin-Wook Kim
Sook-Hyang Jeong
Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
PLoS ONE
title Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
title_full Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
title_fullStr Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
title_full_unstemmed Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
title_short Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition.
title_sort elevated alpha fetoprotein in asymptomatic adults clinical features outcome and association with body composition
url https://doi.org/10.1371/journal.pone.0271407
work_keys_str_mv AT sangmijang elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition
AT gwanghyeonchoi elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition
AT wonchang elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition
AT eunsunjang elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition
AT jinwookkim elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition
AT sookhyangjeong elevatedalphafetoproteininasymptomaticadultsclinicalfeaturesoutcomeandassociationwithbodycomposition